A New Predictor of Mortality in ST-Elevation Myocardial Infarction: The Uric Acid Albumin Ratio

1. Ruff, CT, Braunwald, E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol 2011; 8: 140–147
Google Scholar | Crossref | Medline2. Crea, F, Libby, P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation 2017; 136: 1155-1166.
Google Scholar | Crossref | Medline3. Ibánez, B, James, S, Agewall, S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed) 2017; 70: 1082.
Google Scholar | Crossref | Medline4. Glantzounis, GK, Tsimoyiannis, EC, Kappas, AM, et al. Uric acid and oxidative stress. Curr Pharmaceut Des 2005; 11: 4145–4151.
Google Scholar | Crossref | Medline | ISI5. Feig, DI, Kang, DH, Johnson, RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811–1821.
Google Scholar | Crossref | Medline | ISI6. Kuwabara, M . Hyperuricemia, cardiovascular disease, and hypertension. Pulse (Basel) 2016; 3: 242–252.
Google Scholar | Crossref | Medline7. Krishnan, E . Hyperuricemia and incident heart failure. Circ Heart Fail 2009; 2: 556–562.
Google Scholar | Crossref | Medline8. Valbusa, F, Bertolini, L, Bonapace, S, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013; 112: 499–504.
Google Scholar | Crossref | Medline9. Ndrepepa, G . Uric acid and cardiovascular disease. Clin Chim Acta 2018; 484: 150–163.
Google Scholar | Crossref | Medline10. Chien, SC, Chen, CY, Lin, CF, et al. Critical appraisal of the role of serum albumin in cardiovascular disease. Biomark Res 2017; 5: 31.
Google Scholar | Crossref | Medline11. Don, BR, Kaysen, G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17: 432–437.
Google Scholar | Crossref | Medline | ISI12. Danesh, J, Collins, R, Appleby, P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta–analyses of prospective studies. JAMA 1998; 279: 1477–1482.
Google Scholar | Crossref | Medline | ISI13. Çakmak, EÖ, Bayam, E, Çelik, M, et al. Uric acid–to–albumin ratio: a novel marker for the extent of coronary artery disease in patients with non–st–elevated myocardial infarction. Pulse (Basel) 2021; 8: 99–107.
Google Scholar | Crossref | Medline14. Figtree, GA, Vernon, ST, Hadziosmanovic, N, et al. Mortality in STEMI patients without standard modifiable risk factors: a sex–disaggregated analysis of SWEDEHEART registry data. Lancet 2021; 397: 1085–1094.
Google Scholar | Crossref | Medline15. Appleby, MA, Michaels, AD, Chen, M, et al. Importance of the TIMI frame count: implications for future trials. Curr Contr Trials Cardiovasc Med 2000; 1: 31–34.
Google Scholar | Crossref | Medline16. Steg, PG, James, SK, Atar, D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST–segment elevation. Eur Heart J 2012; 33: 2569–2619.
Google Scholar | Crossref | Medline | ISI17. Alvarez-Lario, B, Macarrón-Vicente, J. Is there anything good in uric acid? QJM 2011; 104: 1015–1024.
Google Scholar | Crossref | Medline18. So, A, Thorens, B. Uric acid transport and disease. J Clin Invest 2010; 120: 1791–1799.
Google Scholar | Crossref | Medline19. Berry, CE, Hare, JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555(Pt 3): 589–606.
Google Scholar | Crossref | Medline | ISI20. Battelli, MG, Polito, L, Bolognesi, A. Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress. Atherosclerosis 2014; 237: 562–567.
Google Scholar | Crossref | Medline21. Patetsios, P, Song, M, Shutze, WP, et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 2001; 88: 188–191.
Google Scholar | Crossref | Medline | ISI22. Gertler, MM, Garn, SM, Levine, SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34: 1421–1431.
Google Scholar | Crossref | Medline | ISI23. Culleton, BF, Larson, MG, Kannel, WB, et al. Serum uric acid and risk for cardiovascular disease and death: the framingham heart study. Ann Intern Med 1999; 131: 7–13.
Google Scholar | Crossref | Medline | ISI24. Zalawadiya, SK, Veeranna, V, Mallikethi-Reddy, S, et al. Uric acid and cardiovascular disease risk reclassification: findings from NHANES III. Eur J Prev Cardiol 2015; 22: 513–518.
Google Scholar | SAGE Journals | ISI25. Chen, JH, Chuang, SY, Chen, HJ, et al. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a chinese cohort study. Arthritis Rheum 2009; 61: 225–232.
Google Scholar | Crossref | Medline26. Strasak, AM, Kelleher, CC, Brant, LJ, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008; 125: 232–239.
Google Scholar | Crossref | Medline | ISI27. Kim, SY, Guevara, JP, Kim, KM, et al. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010; 62: 170–180.
Google Scholar | Medline | ISI28. Zhao, G, Huang, L, Song, M, et al. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis 2013; 231: 61–68.
Google Scholar | Crossref | Medline | ISI29. Braga, F, Pasqualetti, S, Ferraro, S, et al. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med 2016; 54: 7–15.
Google Scholar | Crossref | Medline30. Lazzeri, C, Valente, S, Chiostri, M, et al. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 2010; 138: 206–209.
Google Scholar | Crossref | Medline | ISI31. Kojima, S, Sakamoto, T, Ishihara, M, et al. Japanese acute coronary syndrome study (JACSS) investigators. prognostic usefulness of serum uric acid after acute myocardial infarction (the japanese acute coronary syndrome study). Am J Cardiol 2005; 96: 489–495.
Google Scholar | Crossref | Medline | ISI32. Lazzeri, C, Valente, S, Chiostri, M, et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 2012; 7: 33–39.
Google Scholar | Crossref | Medline | ISI33. Ioachimescu, AG, Brennan, DM, Hoar, BM, et al. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008; 58: 623–630.
Google Scholar | Crossref | Medline34. Sujino, Y, Tanno, J, Nakano, S, et al. Impact of hypoalbuminemia, frailty, and body mass index on early prognosis in older patients (≥85 years) with ST-elevation myocardial infarction. J Cardiol 2015; 66: 263–268.
Google Scholar | Crossref | Medline | ISI35. Plakht, Y, Gilutz, H, Shiyovich, A. Decreased admission serum albumin level is an independent predictor of long–term mortality in hospital survivors of acute myocardial infarction. soroka acute myocardial infarction II (SAMI-II) project. Int J Cardiol 2016; 219: 20–24.
Google Scholar | Crossref | Medline36. Hartopo, AB, Gharini, PP, Setianto, BY. Low serum albumin levels and in-hospital adverse outcomes in acute coronary syndrome. Int Heart J 2010; 51: 221–226.
Google Scholar | Crossref | Medline | ISI37. Oduncu, V, Erkol, A, Karabay, CY, et al. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis 2013; 24: 88–94.
Google Scholar | Crossref | Medline | ISI38. Murat, SN, Kurtul, A, Yarlioglues, M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology 2015; 66: 732–737.
Google Scholar | SAGE Journals | ISI39. Kurtul, A, Ocek, AH, Murat, SN, et al. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Angiology 2015; 66: 278–285.
Google Scholar | SAGE Journals | ISI40. Kurtul, A, Murat, SN, Yarlioglues, M, et al. Usefulness of serum albumin concentration to predict high coronary syntax score and in-hospital mortality in patients with acute coronary syndrome. Angiology 2016; 67: 34–40.
Google Scholar | SAGE Journals | ISI

留言 (0)

沒有登入
gif